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The objective of this study was to identify proteins from Candida species isolated from
HIV-infected African individuals known to be involved in colonization and drug
resistance strategies within the host.
254 oral Candida isolates were collected from HIV-infected South African and
Cameroonian patients presenting with white pseudomembranous plaque on the
tongue or other visible oral candidiasis. Approval from Ministry of Health Regional
Hospital Institutional Review Board (IRB) in Cameroon and from the Ethics
Committee at the University of the Western Cape was obtained.
Confirmation of Candida species was achieved using microscopy, Gram staining and
the germ tube test. Growth on Oxoid and Fluka chromogenic media [2] allowed for
Candida species identification. Presumptive C. albicans and C. dubliniensis isolates
were differentiated by growth at 37˚C for 48 hours in Tomato (V8) agar [3]; at 28˚C for
48-72 hours in Tobacco agar [4] and at 45˚C for 24-48 hours in Sabouraud dextrose
agar [5]. Drug susceptibility testing of the isolates was done using the TREK Sensititre
YeastOne 9 (YO9) system (Thermo Scientific, USA), a CLSI-approved broth micro-
dilution method.
Forty (40) crude cell membrane fractions isolated from the clinical isolates were
prepared using a protein isolation method first described by Niimi et al [6]. The
samples were prepared for mass spectrometry analysis using Filter Aided Sample
Preparation (FASP). These were subsequently analyzed using High Performance
Liquid Chromatography – Mass Spectrometry (HPLC-MS), using a Thermo Scientific
EASY-nLC II connected to a LTQ Orbitrap Velos mass spectrometer (Thermo




Sub-Saharan Africa has one of the highest rates of HIV infection worldwide. Candida
species commonly cause oropharyngeal or systemic dissemination in the HIV-
infected population, leading to an increase in patient morbidity and mortality.
Candidiasis is usually treated with fluconazole in the African continent. This drug acts
by interfering with the synthesis of ergosterol in the fungal cell membrane. However,
drug resistance is known to be on the increase [1], leaving patients with untreated
infections.
The use of proteomic tools for the study of drug resistance in Candida isolates from
the African continent has not been documented.
Introduction: The African continent has the highest burden of HIV infection, accounting
for approximately 65% of new infections globally. Oral candidiasis is a major cause of
increased morbidity in HIV-infected individuals and is usually treated with fluconazole,
an antifungal drug which interferes with ergosterol synthesis in the fungal cell
membrane. The increased resistance of Candida species to antifungal drugs leads to
treatment failure and an increase in untreatable Candida infections.
Objectives/Methods: Drug susceptibility patterns were determined for Candida
species isolated from oral swabs of 254 patients from two HIV-positive African
populations. Forty cell membrane fractions isolated from the clinical isolates were
analyzed using High Performance Liquid Chromatography – Mass Spectrometry
(HPLC-MS) and the results compared to the UniProt protein database for the
identification of Candida peptides known to be involved in colonization and drug
resistance strategies within the host.
Results: Fluconazole-susceptible and –resistant C. albicans isolates were found to
express oxidoreductases that bind mammalian estrogens with high affinity. Peptides
that confer resistance to formaldehyde were found in C. albicans, C. glabrata and C.
dubliniensis in both susceptible and resistant cell fractions. Multidrug resistance
proteins (CDR1 and CDR2) were seen in C. albicans cell fractions.
Conclusion: The combination of different drug resistance mechanisms and binding
abilities to salivary histatins and estrogen seem to be instrumental in the colonisation
and retention of Candida in these immunocompromised patients. The results also
suggest the presence of differences in efflux transporter protein expression in
fluconazole-susceptible and –resistant isolates within the HIV population.
It is known that Candida species express estrogen-binding proteins, which result in a
higher predisposition of females to Candida infection [7]. High performance liquid
chromatography-mass spectrometry analysis of cell surface fractions obtained from
African Candida isolates in this study revealed the presence of oxireductase (probable
NADPH dehydrogenase) proteins that bind to mammalian estrogen with high affinity.
These findings further elucidate the predisposition of females to Candida colonization.
The expression of Candida proteins that are related to colonization and pathogenicity
mechanisms were found in different Candida species, in both drug-susceptible and –
resistant isolates. The combination of different drug resistance mechanisms and
binding abilities to salivary histatins and estrogen found in Candida species through
HPLC-MS analysis seem to be instrumental in the ability of these organisms to
colonize immunocompromised patients and resist the action of different chemicals and
antifungal drugs.
The presence of a multidrug efflux transporter protein (CDR2) known to confer
resistance to azole drugs, which was seen only on a fluconazole-resistant C. albicans
cell fraction, appears to demonstrate differences in the protein expression of
fluconazole-susceptible and –resistant isolates in the HIV population.
Identified proteins of interest included SSA1, SSA2 and 90 homolog salivary histatin-
binding heat-shock proteins, which affect the fungicidal activity of these human
antimicrobial proteins (seen across all tested isolates), estrogen-binding NADPH
dehydrogenase oxidoreductases in C. albicans isolates, pH responsive protein 2 and
multi drug resistance transporter proteins CDR1 and CDR2 in C. albicans isolates
(table 1).
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Table 1: Summary of drug resistance-related Candida proteins identified by HPLC-MS.
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The HPLC-MS data results (acquired using the Xcaliber software package) were
compared to the UniProt protein database for the identification of Candida peptides
known to be involved in colonization and drug resistance strategies within the host.
